Sign In
Buy VIR
$8.66
-0.240 (-2.70%)
At Close: Jul 31, 2026
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
04:05pm, Thursday, 02'nd May 2024
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024. “We are excited to
Vir Biotechnology to Participate in the BofA Securities Healthcare Conference 2024
04:05pm, Tuesday, 30'th Apr 2024
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat
What Makes Vir Biotechnology (VIR) a New Buy Stock
01:01pm, Wednesday, 24'th Apr 2024
Vir Biotechnology (VIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D.
08:00am, Thursday, 18'th Apr 2024
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board
Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
04:30pm, Thursday, 11'th Apr 2024
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31, 202
From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
02:58pm, Tuesday, 19'th Mar 2024
Given the current risk-on sentiment, it is perhaps an ideal time for investors to scoop up some of the top biotech stocks. The stock market is booming, and with investors looking to take on more risk
Billionaire's Biotech Bets: 3 Stocks Dominating Bill Gates' Portfolio
11:07am, Wednesday, 13'th Mar 2024
Since Bill Gates left his position with Microsoft (NASDAQ: MSFT ) he diversified his stock portfolio away from the tech giant. Instead, biotechnology has been is primary interest.
Vir Biotechnology: Making Progress In Hepatitis B And Hepatitis Delta
11:56pm, Tuesday, 27'th Feb 2024
Vir Biotechnology is developing treatments for Hepatitis B, Hepatitis Delta, HIV, and COVID, among others.
3 Highly Rated Biotech Stocks to Buy for 300% Gains
06:55am, Monday, 26'th Feb 2024
Investors know that the world of biotech stocks is home to a great percentage of opportunities that can triple and quadruple their capital. It's also fairly easy to identify such stocks using screener
Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade
10:56am, Friday, 23'rd Feb 2024
The consensus price target hints at an 186.4% upside potential for Vir Biotechnology, Inc. (VIR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in e
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
08:05am, Friday, 23'rd Feb 2024
SAN FRANCISCO--(BUSINESS WIRE)---- $VIR--Vir Biotechnology to participate in upcoming March investor healthcare conferences.
Vir Biotechnology, Inc. (VIR) Q4 2023 Earnings Call Transcript
08:48pm, Thursday, 22'nd Feb 2024
Vir Biotechnology, Inc. (VIR) Q4 2023 Earnings Call Transcript
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
06:51pm, Thursday, 22'nd Feb 2024
Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.86 per share versus the Zacks Consensus Estimate of a loss of $1.14. This compares to loss of $0.76 per share a year ago.
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Thursday, 22'nd Feb 2024
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2023. “
Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
04:05pm, Thursday, 01'st Feb 2024
SAN FRANCISCO--(BUSINESS WIRE)---- $VIR--Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024.
